Oura files Nasdaq IPO as $11bn valuation meets profit surge

Oura Inc. has filed for a U.S. initial public offering under the proposed Nasdaq ticker OURA, opening its financial statements just as the smart-ring company moves from rapid private-market expansion into sustained profitability. Revenue reached $1.2145 billion during the nine months ended June 30, 2026, up 74% from $697.6 million a year earlier, while net income increased to $60.8 million from only $1.6 million. Oura had 5 million paid members at June 30, double the 2.5 million recorded a year earlier, and generated $240.5 million of membership revenue with an 89% membership gross margin. The company has not yet disclosed an IPO price range, share count or intended proceeds, leaving its final public valuation unresolved after a 2025 financing led by Fidelity valued Oura at approximately $11 billion. The central question is whether public investors will regard Oura primarily as a premium hardware business exposed to product cycles or as a health-data subscription platform whose rapidly expanding membership economics justify a substantially higher valuation.

Why does Oura’s 74% revenue growth look stronger now that the company is producing real profit?

Oura’s growth has accelerated from a much larger base than it had only two years ago. Fiscal 2025 hardware revenue reached $749.4 million and membership revenue was $158.5 million, producing total revenue of approximately $907.9 million. During just the first nine months of fiscal 2026, total revenue had already reached $1.2145 billion, approximately 34% above the entire prior fiscal year before Oura had even completed its September year-end.

The quality of the earnings improvement is equally important. Net income reached $60.8 million during the nine-month period compared with $1.6 million a year earlier, while adjusted EBITDA increased to $106.7 million from $83.5 million. Oura’s nine-month net margin was therefore approximately 5%, while adjusted EBITDA margin was about 9%, showing that this is no longer merely a hardware-growth story financed by persistent operating losses.

Cash generation provides another useful signal. Oura generated $328 million of operating cash flow during the nine months ended June 30, up from $135.3 million a year earlier, even while increasing investment in production capacity, tooling, retail displays and office infrastructure. Net investing cash outflow was $77 million during the period, meaning operating cash generation significantly exceeded those reported investing requirements.

The improvement should still be interpreted cautiously because working capital contributed significantly to cash flow, including changes in inventory, deferred revenue and accounts payable around the Oura Ring 5 production ramp. Even so, profitable growth accompanied by positive operating cash flow gives the IPO a fundamentally different profile from consumer-hardware businesses seeking public capital before reaching economic scale.

What does Oura’s previous $11 billion valuation imply against its newly disclosed revenue base?

Oura secured more than $900 million in financing in October 2025 in a round led by Fidelity Management & Research Company, with participation from investors including ICONIQ, Whale Rock and Atreides. The transaction valued the company at approximately $11 billion, more than twice the roughly $5.2 billion valuation associated with its prior financing.

Against fiscal 2025 revenue of approximately $907.9 million, the $11 billion private valuation represented roughly 12.1 times historical annual revenue. Using the latest nine-month revenue of $1.2145 billion without annualising it reduces that relationship to roughly 9.1 times revenue already generated during the first three quarters of fiscal 2026. These are Business News Today calculations intended to illustrate how rapidly revenue growth has reduced Oura’s historical valuation multiple.

Annualising the latest nine-month revenue mechanically would produce approximately $1.62 billion, which would put the previous $11 billion valuation at about 6.8 times that simple annualised figure. Such an extrapolation is not company guidance and could be affected by product-launch timing and seasonality, but it demonstrates why the forthcoming IPO valuation could exceed the last private reference even without the multiple expanding.

Oura has not disclosed what valuation it intends to pursue on Nasdaq. That absence is important because an IPO priced near $11 billion would offer public investors substantially stronger underlying financials than the private investors who entered at that level in 2025, while a materially higher valuation would require the market to capitalise much more of the company’s future membership and healthcare opportunity immediately.

Why could 5 million paid members become more important than the number of Oura Rings sold?

Oura’s strongest argument for being valued differently from a conventional electronics company is its subscription base. Paid membership increased from 1.5 million at the end of December 2024 to 5 million at June 30, 2026, while year-over-year membership growth exceeded 100% for seven consecutive quarters. More than 94% of ring activations have historically converted into paid membership after the initial trial period, linking hardware acquisition directly to recurring software revenue.

Membership revenue reached $240.5 million during the first nine months of fiscal 2026, up 121% from $108.8 million. More importantly, the business generated an 89% membership gross margin, far higher than the economics normally associated with physical wearable devices. Approximately 63% of new members began with annual rather than monthly subscriptions, potentially improving retention and cash-flow visibility.

Oura charges $5.99 per month or $69.99 annually in the United States. Its weighted-average 12-month paid-member retention stood at approximately 85% at June 30, while daily active users represented about 65% of monthly active users during the first three quarters of fiscal 2026. Paid members opened the Oura app more than 3.5 times per day on average, suggesting the subscription is being used as an ongoing health service rather than simply accompanying an occasional device purchase.

The subscription base creates compounding economics because one ring sale can produce membership revenue across several years. If membership continues becoming a larger proportion of total revenue, Oura’s blended margins and revenue predictability could improve even if hardware unit growth eventually slows.

Is Oura still fundamentally a hardware business despite the subscription story?

For now, the answer is yes. Hardware represented approximately 80% of revenue during the nine months ended June 30, compared with 20% from membership. Oura itself warns that substantially all of its revenue still depends on the Oura Ring and associated membership, meaning weakness in hardware demand would also reduce the flow of new subscribers.

Oura sold 3.6 million rings during the 12 months ended June 30, approximately 2% of the 212 million units the company says were shipped across the global wearables market during the same period. That relatively low penetration supports the growth argument because Oura does not need to dominate wearables globally to expand substantially from its current unit base.

The hardware economics have also been evolving. Average revenue per unit was $311 during the first nine months of fiscal 2026, down from $326 in fiscal 2025, reflecting distribution mix, promotions and partnerships. Oura Ring 5 launched in June with U.S. starting prices between $399 and $499, while the company says its redesign is approximately 40% smaller than Oura Ring 4.

The long-term valuation therefore depends on whether hardware increasingly acts as the customer-acquisition engine for a higher-margin service rather than remaining the principal source of economic value itself. Oura has already made progress in that direction because membership revenue grew substantially faster than hardware revenue during the latest nine-month period.

Can Oura’s 89% membership margin materially change the economics of the entire company?

The difference between subscription and hardware margins is central to the IPO thesis. Total company gross margin improved from 51% to 55% year over year during the first nine months of fiscal 2026, while membership gross margin reached 89%. If membership becomes a larger proportion of revenue without undermining ring demand, the revenue mix can naturally push consolidated margins higher.

Membership already increased from 16% of revenue during the first nine months of fiscal 2025 to 20% during the corresponding 2026 period. Hardware revenue still increased 65% to $974 million, so the subscription mix is expanding because membership is growing faster rather than because hardware is shrinking. That is a considerably healthier form of recurring-revenue transition than attempting to replace a declining device franchise.

The economics could become powerful if paid members continue growing near current rates, but investors should not extrapolate 100%-plus subscriber growth indefinitely. Oura itself warns that membership growth rates will moderate as the installed base becomes larger, and retention becomes increasingly important once new-member additions naturally slow.

The key metric after listing will therefore not simply be membership revenue growth. Investors will need to track the combination of paid members, retention, subscription mix and hardware-acquisition efficiency to determine whether Oura is building durable lifetime value or merely adding subscribers during an unusually strong hardware cycle.

Why does Oura’s move into 8,400 retail locations create both growth and margin risk?

Oura began primarily as a direct-to-consumer business but has rapidly developed an omnichannel distribution strategy. The company now reaches approximately 8,400 retail locations globally through partners including Amazon, Best Buy, Costco, Target, Walmart, Harrods, John Lewis and JB Hi-Fi. During fiscal 2025 it entered 20 new markets and added 39 retail partners, followed by another 15 markets and 70 partners during the first three quarters of fiscal 2026.

Retail already accounted for approximately 49% of hardware revenue during the nine months ended June 30. Physical stores solve a particular problem for smart rings because consumers need confidence around sizing, fit and comfort before buying a relatively expensive wearable. Retail availability also puts Oura in front of shoppers who may never visit its direct website.

The trade-off is channel economics and concentration. Large retailers capture part of the product margin and can influence promotions, purchasing volumes and inventory requirements. Oura warns that retail partners generally are not required to purchase meaningful minimum quantities, leaving the company exposed if major chains reduce orders or change vendor strategy.

International expansion remains comparatively early, which provides additional runway. Less than 20% of hardware revenue during the first nine months of fiscal 2026 came from outside the United States. That means Oura has built a billion-dollar-plus revenue business while still generating more than four-fifths of hardware sales domestically, leaving Europe and Asia as potentially substantial future growth markets.

How serious are Oura Ring 4 battery problems as the company brings Ring 5 to public investors?

The S-1 contains a useful reminder that premium wearables remain exposed to physical product risk. Oura disclosed elevated battery-performance issues affecting certain cohorts of Oura Ring 4, leading the company to replace affected devices under warranty and, in some cases, outside formal warranty periods. Fiscal 2025 cost of revenue included an $84.4 million increase in warranty expense associated with elevated reserves for those battery issues.

That amount is financially significant relative to Oura’s historical profitability. Fiscal 2025 ended with essentially break-even net income despite rapid revenue growth, in part because the company was absorbing product-launch costs, warranty expenses and substantial increases in sales, marketing and research expenditure. The stronger 2026 profit therefore partly reflects a business moving beyond those earlier launch pressures.

Oura Ring 5 now creates a new product-quality test. The company says it has redesigned the device with a smaller titanium structure, improved sensor contact, more efficient LEDs and 12 stronger signal pathways, but it explicitly warns investors that future generations could experience defects or warranty costs similar to Ring 4.

This risk matters more because hardware and membership are economically linked. A defective ring does not merely create a replacement expense; it can reduce member engagement, damage retention and affect future hardware upgrades. Maintaining product reliability is therefore essential to protecting both sides of Oura’s business model.

Could preventative healthcare become a larger market for Oura than consumer wearables?

Oura is presenting itself as more than an activity tracker. The platform generates more than 50 health and wellness metrics spanning sleep, activity, readiness, stress, cardiovascular signals, metabolic health and women’s health. Oura estimates that the preventative-health opportunity accessible to its platform represents more than $90 billion of serviceable spending, although that figure is the company’s own market estimate rather than recognised revenue.

The healthcare opportunity could broaden the company beyond individual consumer subscriptions. Oura already has relationships with corporate and enterprise customers, including the U.S. Department of Defense, and integrates with health-related services from partners including Natural Cycles and Dexcom. Certain features are regulated as medical devices in some jurisdictions, meaning the company is gradually moving closer to the boundary between wellness technology and regulated healthcare.

That creates a potentially valuable strategic path. A wearable collecting approximately 23 hours of biometric data per member per day can produce longitudinal datasets useful for early detection, research and personalised care if the underlying measurements remain accurate enough for those applications. Oura argues that continual use improves its ability to establish individual physiological baselines rather than relying only on population-level averages.

The regulatory burden rises as the company moves deeper into healthcare. Features positioned as medical devices require additional evidence, approvals, quality controls and compliance obligations, while health data itself attracts significant privacy scrutiny. Oura could obtain a larger addressable market by becoming more medically relevant, but it also becomes a more regulated company in the process.

Does Oura have enough balance-sheet strength to enter the IPO without depending on public capital?

Oura had $371.8 million of cash and cash equivalents at June 30 and approximately $380.1 million of debt. On a simple comparison, gross debt therefore exceeded cash by only about $8.4 million, although the actual net-debt calculation can differ depending on restricted cash, debt classification and other balance-sheet items.

More importantly, operating cash flow reached $328 million during the first nine months of fiscal 2026. That means the IPO does not resemble a financing required to keep the company solvent or sustain a structurally cash-burning operation. Oura has not yet disclosed how much capital it intends to sell or the precise uses of the eventual IPO proceeds.

This gives management flexibility around pricing. Companies that urgently need cash can be forced to accept weaker valuations when markets become volatile, whereas Oura can theoretically prioritise valuation, shareholder liquidity and public-market positioning rather than immediate financial survival.

The extensive underwriting group also suggests a sizeable institutional offering is being prepared. Goldman Sachs, Morgan Stanley, J.P. Morgan, Allen & Company and BofA Securities are among the lead banks, with the offering expected to trade on Nasdaq under OURA once pricing is completed.

What are the key takeaways from Oura’s Nasdaq IPO filing?

• Oura filed its Form S-1 on September 3 and intends to list on Nasdaq under the ticker OURA.
• The company has not yet disclosed an IPO price range, share count, proceeds target or public-market valuation.
• Revenue increased 74% to $1.2145 billion during the nine months ended June 30, 2026.
• Net income increased to $60.8 million from $1.6 million, while adjusted EBITDA reached $106.7 million.
• Operating cash flow increased to $328 million during the nine-month period.
• Oura had 5 million paid members at June 30, double the number from a year earlier.
• Membership revenue increased 121% to $240.5 million and generated an 89% gross margin.
• Hardware still contributed approximately 80% of total revenue, while membership accounted for 20%.
• Oura sold 3.6 million rings during the 12 months ended June 30, equivalent to approximately 2% of global wearable shipments according to the company.
• Oura’s previous financing led by Fidelity valued the company at approximately $11 billion.
• Retail generated 49% of hardware revenue, while less than 20% of hardware revenue came from outside the United States.
• Oura Ring 4 battery problems produced elevated warranty costs, making product reliability an important risk as Ring 5 scales.

What will determine whether Oura deserves a health-platform valuation rather than a hardware multiple?

Oura reaches public markets with something many consumer-device companies struggle to achieve: hardware growth, recurring revenue and actual profitability at the same time. The ring remains the economic gateway into the ecosystem, but the 5 million-member subscription base is becoming large enough to change how investors can think about the company. An 89% membership gross margin and 85% 12-month retention provide evidence that the software layer has meaningful standalone economic value.

The thesis strengthens if membership continues growing faster than hardware, lifting subscription revenue above the current 20% share while consolidated gross margins improve. International expansion also offers substantial upside because more than 80% of current hardware revenue still comes from the United States despite Oura already reaching thousands of retail locations worldwide.

The thesis becomes considerably stronger if healthcare partnerships develop into material revenue streams. Employer programmes, health plans, clinical applications and regulated features could turn the ring from a premium consumer accessory into a recurring healthcare interface, potentially expanding lifetime value without requiring a proportional increase in device sales.

The risks are equally clear. Oura still depends almost entirely on one hardware family, retail partners account for nearly half of hardware revenue and product-quality problems can simultaneously increase warranty costs and damage subscription retention. Apple, Samsung, Garmin and other wearable competitors also possess much larger consumer ecosystems, while specialised smart-ring rivals continue targeting the same form factor.

An $11 billion private valuation was already demanding when Oura completed its Series E last year. The company has since supplied a much stronger financial case by producing $1.21 billion of nine-month revenue, $60.8 million of profit and $328 million of operating cash flow.

The IPO therefore arrives at a useful inflection point. Public investors will not have to decide whether consumers want smart rings because Oura has already demonstrated substantial demand. They will instead decide something more consequential: whether selling millions of rings is the end product of the business or simply the acquisition mechanism for a much larger recurring health-data platform.